If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Taltz ® (ixekizumab) injection
80 mg/mLThis information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
There are no recommendations for monitoring ixekizumab drug levels, or for adjusting ixekizumab dose based on blood levels. There are no commercially available assays at this time.
Enclosed Prescribing Information
TALTZ® (ixekizumab) injection, for subcutaneous administration, Lilly
Date of Last Review: June 10, 2020
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon - Fri, 9am - 7pm EST